Dr. Vargas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-7500Fax+1 415-502-6361- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Psychiatry, 1997 - 2001
University of California, Irvine, School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2026
Publications & Presentations
PubMed
- 26 citationsReduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humansNarender R. Gavva, Robert W Sandrock, Gregory E. Arnold, Michael T. Davis, Edwin Lamas, Chris Lindvay, Chi-Ming Li, Brian Smith, Miroslav Backonja, Kristin Gabriel, Ga...> ;Scientific Reports. 2019 Dec 23
- 26 citationsPhase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure...Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Marissa Herbots, Yumi Kubo, Edward Lee, Osa Eisele, Gabriel Vargas, Kristin Gabriel> ;Cephalalgia. 2019 Jan 1
- 56 citationsPhase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine.Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Lucy Yan, Brian Smith, Jiyun Sunny Chen, Edgar Bautista, Lisa Hamilton, Javier Waksman, Thuy Vu, Gabriel Vargas> ;Clinical Pharmacology and Therapeutics. 2018 May 1
- Join now to see all
Press Mentions
CuraSen Therapeutics Presents Phase 1b Clinical Data with CST-103 Demonstrating Significant Increases in Cerebral Blood Flow in Patients with Mild Cognitive Impairment or Parkinson’s DiseaseNovember 9th, 2021- Faculty, Students, and Family Attend USU Memorial to ‘First Patients’May 26th, 2021
- CuraSen Therapeutics Announces Phase 1 Clinical Data Demonstrating That Salbutamol, a Beta-2 Adrenoceptor Agonist, Significantly Increases Cerebral Perfusion, a Key Marker in Neurodegenerative DiseaseMarch 15th, 2021
- Join now to see all
Grant Support
- Membrane Trafficking Regulation Of Dopamine ReceptorsNational Institute Of Mental Health2003–2006
Other Languages
- Spanish
Hospital Affiliations
- UChicago Medicine Ingalls MemorialHarvey, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
